Trials / Completed
CompletedNCT04448132
Evaluation of Persistence of Immunity in 4-year-old Children Previously Immunised With IPV-Al AJV (Picovax®)
Evaluation of the Persistence of the Immunity in 4-year-old Children Previously Immunised With an Adjuvanted Reduced Dose Inactivated Polio Vaccine, IPV-Al AJV (Picovax®) by Measuring the Response to an Additional Dose of IPV-Al AJV
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 163 (actual)
- Sponsor
- AJ Vaccines A/S · Industry
- Sex
- All
- Age
- 4 Years – 4 Years
- Healthy volunteers
- Accepted
Summary
The trial is a phase 4, open-label, multicentre clinical trial with healthy subjects who have been vaccinated with IPV-Al AJV at 2, 4, 6 and 15 18 months of age in previous trials. Levels of antibodies against poliovirus types 1, 2 and 3 after immunisation with IPV Al AJV will be measured in the trial subjects at the age of 4 years. An additional IPV-Al AJV dose (investigational vaccine) will be administered and the booster response to IPV-Al AJV will be investigated one month after administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | IPV-Al | adjuvanted reduced dose inactivated polio vaccine |
Timeline
- Start date
- 2020-11-20
- Primary completion
- 2021-05-03
- Completion
- 2021-05-03
- First posted
- 2020-06-25
- Last updated
- 2021-06-22
Locations
1 site across 1 country: Panama
Source: ClinicalTrials.gov record NCT04448132. Inclusion in this directory is not an endorsement.